Kundu Sourav 4
4 · NextCure, Inc. · Filed Feb 2, 2022
Insider Transaction Report
Form 4
NextCure, Inc.NXTC
Kundu Sourav
Sr VP, Dev. & Mfg.
Transactions
- Award
Employee Stock Option (Right to Buy)
2022-01-31+58,700→ 58,700 totalExercise: $5.57Exp: 2032-01-30→ Common Stock (58,700 underlying)
Footnotes (1)
- [F1]One fourth of the option vests on January 31, 2023. The remainder vests in 36 monthly installments beginning on February 28, 2023.